NDC 11994-006

NEUROLITE

Bicisate Dihydrochloride

NEUROLITE is a Intravenous Kit in the Human Prescription Drug category. It is labeled and distributed by Lantheus Medical Imaging, Inc.. The primary component is .

• Product ID: 11994-006_2c4c26b2-f5ad-4f9a-bf26-a0934a75a48b
• NDC: 11994-006
• Product Type: Human Prescription Drug
• Proprietary Name: NEUROLITE
• Generic Name: Bicisate Dihydrochloride
• Dosage Form: Kit
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 1994-11-23
• Marketing Category: NDA / NDA
• Application Number: NDA020256
• Labeler Name: Lantheus Medical Imaging, Inc.
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 11994-006-02

2 KIT in 1 PACKAGE, COMBINATION (11994-006-02) > 1 KIT in 1 KIT * 1 INJECTION in 1 VIAL (11994-002-01) * 1 mL in 1 VIAL (11994-004-01)

• Marketing Start Date: 1994-11-23
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 11994-006-02 [11994000602]

NEUROLITE KIT

• Marketing Category: NDA
• Application Number: NDA020256
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1994-11-23

NDC 11994-006-05 [11994000605]

NEUROLITE KIT

• Marketing Category: NDA
• Application Number: NDA020256
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1994-11-23

Drug Details

OpenFDA Data

• SPL SET ID: f9adbcd5-1ac1-42d8-b18a-a76c9204014c
• Manufacturer:
  • Lantheus Medical Imaging, Inc.